Two cases of idiopathic membranous nephropathy treated with rituximab

Abstract Idiopathic membranous nephropathy is a common cause of nephrotic syndrome, and has been reported as a cause of idiopathic primary glomerulonephropathy in up to 90% of patients. However, the treatment options remain controversial. We report two cases of idiopathic membranous nephropathy that...

Full description

Saved in:
Bibliographic Details
Published in:Kidney research and clinical practice 2013, 32(3), , pp.138-141
Main Authors: Young Yoon, Jae, Tae Han, Seung, Cho, Ajin, Ryoun Jang, Hye, Eun Lee, Jung, Huh, Wooseong, Joong Kim, Dae, Young Oh, Ha, Kim, Yoon-Goo
Format: Article
Language:English
Subjects:
Case Report
Idiopathic membranous nephropathy
Nephrology
Nephrotic syndrome
Proteinuria
Rituximab
내과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Idiopathic membranous nephropathy is a common cause of nephrotic syndrome, and has been reported as a cause of idiopathic primary glomerulonephropathy in up to 90% of patients. However, the treatment options remain controversial. We report two cases of idiopathic membranous nephropathy that were treated with rituximab. A 54-year-old man and a 64-year old man were admitted for rituximab therapy. They had previously been treated with combinations of immunosuppressive agents including cyclophosphamide, cyclosporine, mycophenolate, and steroids. However, the patients' heavy proteinuria was not resolved. Both patients received rituximab therapy, 2 weeks apart. After several months of follow-up and a second round of rituximab treatment for each patient, their proteinuria decreased and partial remission of disease was achieved in both patients.
ISSN:2211-9132
2211-9140
DOI:10.1016/j.krcp.2013.06.003